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Abstract— Measurement systems for early and reliable detec-
tion of degenerative diseases, such as Alzheimer’s disease (AD),
are extremely important in clinical diagnosis. Among these,
biochemical assays represent a commonly used method to dis-
tinguish patients from healthy population thanks to the sensitive
recognition of specific biomarkers in biological fluids. In order
to overcome actual limitations of these techniques in term
of cost, standardization, and sensitivity, this study aimed to
realize a low-cost highly sensitive portable point-of-care (PoC)
testing system based on screen-printed electrochemical sensors.
The development of the platform specifically included both the
design of the sensing probe and the electronic circuit devoted
to condition and acquires the transduced electric signal. The
designed circuit was implemented in a printed circuit board
and interfaced to a wireless system based on bluetooth data
transmission in order to improve the portability of the proposed
solution. Preliminary results were obtained by using controlled
concentrations of electrolytic solutions and calibrating the sensors
for antibodies and for a well-known protein (i.e., interleukin 8)
quantified by anodic stripping voltammetry (ASV). Findings from
ASV measurements showed a sensitivity of 38 µA/(ng/ml) with a
tested range from 1.25 to 20 ng/ml, with a limit of detection of
2 ng/ml. Further investigation will include the validation of this
PoC device by testing the concentration of a specific p53 protein
isoform, which was recently identified to early correlate to
AD development.
Index Terms— Electrochemical biosensors, point-of-care (PoC)
testing, screen printing, voltammetry, wireless data acquisition
device.
I. INTRODUCTION
RECENTLY, one of the most pervasive challenges ofelectronics and engineering applied to biotechnologi-
cal and clinical research has been represented by the abil-
ity to develop specific measurement devices with integrated
technologies able to identify—quickly, diffusely, and with a
very high sensitivity—specific disease-related proteins and
biomolecules, defined as “biomarkers.” In this perspective,
new rapid, low cost and easily accessible methodologies and
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technologies have been increasingly investigated—including
medical devices for in vitro diagnosis and point-of-care (PoC)
systems—supported also by the growing interest toward cus-
tomized and personalized medicine and toward rapid and
home-accessible portable diagnostic systems [1]–[3].
Portable and self-standing devices, fundamental for PoC
applications, can be realized by integrating proper sensing
devices with conditioning and acquisition circuit [1].
Different technologies can be adopted in order to realize
biosensors integrated in lab-on-a-chip devices, promising path
to reduce time, cost, and quantity of sample required to
perform the analysis [2]. Furthermore, user safety and sample
sterility can also be addressed by implementing wireless
module, as highlighted in [3].
Among the different techniques investigated, electrochem-
ical biosensors represent the ideal starting point to realize
complete testing platforms for biological biomarker quan-
tification. More specifically, screen-printed electrochemical
sensors (SPES), thanks to their ability to be functionalized
and customized for the detection of different analytes (e.g.,
DNA, proteins), have acquired a predominant importance
in the last decade. Printed electronics presents a successful
approach to develop low-cost solutions, with the possibility to
increase the level of standardization, to reduce sample volumes
required for each analysis and to customize the surface for a
more efficient functionalization. In particular, literature reports
different studies based on screen printing (also defined as thick
film printing) to realize electrochemical sensors addressing the
sensitive and specific quantification of different proteins and
biomolecules [4], [5].
Electrochemistry offers a wide variety of techniques to
detect and quantify specific biomolecules using SPES, includ-
ing the possibility to both completely immerse the sensor in
a buffer solution [6] or just cover it with a small volume of
sample [7]. All the electrochemical approaches could be very
fundamental in PoC implementation, since they can associate
an improved quantitative analysis, with the possibility to
maintain a wet setup with functionalization, using a protocol
similar to the one usually implemented for enzyme-linked
immunosorbent assays (ELISA).
According to the signal recorded, these techniques
can be divided into impedance based and voltammetry
methods. Among the first group, electrochemical impedance
spectroscopy (EIS) represents a label-free method useful
for protein and biomolecules quantification, particularly
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interesting due to its ability to detect variations in resistance
and capacitance upon binding events. EIS principle is based
on the measurement of the changes of impedance deriving
from a different electrons exchange at the interface between
the functionalized surface of the electrode and a conductive
solution. Considering the same setup, these changes are in
particular related only to the concentration of the recognized
proteins [9]. Differently from EIS, in all the voltammetric
techniques, information about the analyte is obtained by
measuring the current as the potential of the electrode is varied.
Even if with differences between the specific biomolecules,
detection is performed labeling target analytes with selected
redox reactive species, thus to correlate an electrical signal
proportional to the amount of analyte recognized. Among
voltammetric methods, anodic stripping voltammetry (ASV)
represents one of the most promising compared to any other
electrochemical techniques, able to increase of sensitivity
of others 2 or 3 orders of magnitude, reaching limit of
detection (LOD) in the range of 10−9 to 10−10 M. In ASV,
a metal is deposited on the surface of the electrodes during
a preconcentration step, and it is then stripped applying an
oxidizing potential. In addition to heavy metals quantification,
interesting applications of ASV for proteins [7], biomolecules
[11], Deoxyribonucleic acid (DNA) sequences [12] have
been investigated. Labeling proteins with specific catalyzing
enzymes, proteins concentration can be indirectly quantified
as proportional to the amount of metal deposited by measuring
current peak metal during the stripping step.
Similarly, for both EIS and voltammetry, a three-electrode
configuration is usually implemented. This configuration,
including a working, counter and reference electrode (Working
Electrode (WE), Counter Electrodes (CE), and Reference
Electrode (RE)), is most common for typical electrochemical
applications, especially when the potential across the electro-
chemical interface need to be measured accurately, in order to
ensure stability of the cell [8].
Concerning the integration of the conditioning circuit in
the design of PoC systems or monitoring devices, we can
find different examples in the very recent literature, which
tried to improve different clinical issues related to rapidity
of assays, portability, implantability, and sensitivity. More
specifically in order to allow an efficient transduction of
physiological processes into quantifiable signal, combinations
of potentiostats and galvanostats standard designs have been
investigated in different solutions [13]. Additionally, a great
interest was related to combine innovative detection techniques
(including label-free techniques based on optical, mechanical
and electrochemical transducers) with their optimal condi-
tioning circuit in order to realize fast, portable, and easily
usable devices aiming to smart bio sensing and to bring a
significant improvement to clinical daily practice [3], [14].
However, among the various technologies proposed for the
realization of PoC systems, no reliable, quantitative, and
sensitive devices for specific protein detection have been yet
commercialized.
Therefore, our specific aim is to apply these challeng-
ing up-and-coming PoC concept, extending previous pre-
liminary analyses [15], in order to realize a self-standing
portable device, which could be useful for the sensitive
quantification of protein in biomarkers detection.
In particular, the interest of this paper concerned the real-
ization of a platform for biomarkers involved in the early
diagnosis of Alzheimer’s disease (AD). Among neurodegener-
ative diseases, one of the most pervasive challenges is in fact
related to the ability to detect AD in its earliest stage [16], by
using different strategies, including cognitive tests, neuroimag-
ing [17], [18], genetic profiling and biomarkers. Peripheral
AD biomarkers in particular have recently attracted attention
for their minimally invasive approach [19], stimulating the
discussion and investigation on different novel techniques.
Specifically, a peculiar expression of an altered conformational
isoform of p53 protein was reported to be able to distinguish
AD subjects from healthy population, demonstrating high
values of sensitivity and specificity [20]. So far, quantification
of this protein can be performed in clinical and biological
laboratories by using a specific ELISA assay starting from
peripheral blood samples. However, this technique presents
issues in term of time and cost effectiveness, required sample
volume, inter- and intrarater reliability, and possibility of
quantification.
In this perspective, focusing on the quantification of bio-
markers for early detection of AD, but without losing the
possibility of generalization, this paper aimed to complete and
improve results obtained in previous preliminary analyses [15],
introducing a system able to perform a sensitive and reliable
analysis, with operator-friendly characteristic and wireless
transmission of data aiming at improving portability.
Therefore, here is presented a complete system consisting
of a SPES with six measuring points and an electronic
microprocessor-based system, designed to wirelessly transmit
data, thus to increase the overall portability of the solution.
Particular attention was given to the choice of the SPES
materials and geometry, the electronic circuit devoted to the
conditioning and acquisition of the electric signal, and to
the electronic microprocessor-based solution that can transmit
data wirelessly. Several characterization measurements were
also obtained with the presented system and further design
considerations and critical analyses are reported.
II. SYSTEM DESCRIPTION, MATERIALS, AND METHODS
The proposed PoC is composed by three main parts (Fig. 1):
1) the screen-printed sensing probe, which can be functional-
ized using different antibodies for the detection of specific
biomarkers; 2) the signal conditioning circuit designed to
ensure highly precise and sensitive measurements, thus to
register small changes in ionic current during ASV testing
protocols; and 3) the wireless Bluetooth system for signal
acquisition.
A. Sensors Design and Production
Sensor layout was designed using a software called
QCAD (QCAD.org). Each layer, corresponding to a different
conducting material, was separately designed, in order to
produce the masks required to screen print—layer-by-layer—
the final structure of the sensor. Conductive tracks were
designed with particular care using a resolution compatible
This article has been accepted for inclusion in a future issue of this journal. Content is final as presented, with the exception of pagination.
TONELLO et al.: WIRELESS PoC PLATFORM 3
Fig. 1. Schematic of the proposed PoC testing platform.
with the adopted screen printer (A2 Model, Baccini srl,
Italy). The geometry—with WEs of 5 mm of diameter—was
optimized from a single to a multiwell design. This specific
configuration allows reducing variability, improving the
performances when testing duplicates or different biomarkers
during same analysis. Following a standard procedure, final
geometry was printed on a lucid sheet by means of inkjet
printing, thus to allow the realization by UV photolithography
of a 40-μm-thick blocking stencil, i.e., the mask required
for the screen printing process. Specifically, a silver ink
(CI 1001, electrical resistance <0.015 ohms/square, viscosity
14 Pa s at 30 °C) was selected to realize the conductive
tracks. Carbon ink was selected to realize the WE and CE
of the biosensor. Among the materials available for SPES
production (e.g., carbon, gold, platinum), carbon represents
the best compromise in term of cost—essential requirement
when designing a PoC device—biocompatibility—in
order to ensure a proper functionalization—and electronic
performances—in order to allow signal transduction during
ASV measurements [21]. Finally, a silver–silver chloride ink
(CI 4002, electrical resistance < 0.050 −2, viscosity 5 Pa
s at 30 °C) thanks to its inert chemical composition, was
selected to realize the RE. All the conductive pastes were
purchased from ECM—Engineered Conductive Materials
(Engineered Material System Inc.). Using a screen with
250 meshes with apertures forming angles of 45°, the three
layers were consequently printed on a 0.4-mm-thick alumina
substrate: first silver, then carbon and finally silver–silver
chloride. Each layer was cured in an oven, specifically silver
inks for 10 min at 110 °C and carbon ink 5 min at 130 °C.
After the printing process was completed, in order to allow
a better conduction of the signal, the conductive tracks were
covered by using a transparent spray (RS Components, U.K.)
specifically adopted in printed electronics as a protecting
layer to ensure proper electrical insulation. This operation
only leaves the terminal part of the tracks uncoated, thus to
allow the connection with the conditioning circuit (Fig. 2).
B. Circuit Design and Production
Following the completion of the SPES final layout,
a dedicated acquisition system was designed in order to allow
the production of a complete PoC testing platform.
Fig. 2. Final SPES layout.
The testing solution is basically composed of one Arduino
UNO board, a custom conditioning circuit and a bluetooth
module. For the dual-voltage supply (±5 V), two lithium-
ion batteries were adopted. Arduino UNO board generates the
signal required to drive the measurement. Since Arduino UNO
is not able to generate an analog signal, it communicates with
the 16-b digital-to-analog converter (16-b DAC) over serial
peripheral interface in order to obtain an analog signal (Vin),
as input for the conditioning circuit. The design of the analog
front end was performed to obtain ASV measurements (Fig. 3).
In particular, the desired potential is applied to the cell by
controlling the potential of RE with respect to the WE and,
thanks to the electrons movement generated by the effect of
the electromotive force applied in the sample, the generated
current can be detected between WE and CEs. The last
stage was developed to make the output of the OPA129
suitable for the Arduino analog input. Indeed, the OPA129
output can be positive or negative while the analog input of
Arduino can be only positive. Operational amplifiers were
carefully selected depending on the specific function they
had to perform in the circuit. In order to guarantee a high
accuracy in the control of the input voltage to the sensor, preci-
sion bipolar amplifiers were selected [OPA177GS from Texas
Instrument (TI)], with very low offset voltage, drift, and low
noise. In order to allow low-current measurements with high
precision and low bias, the current-to-voltage converter was
realized using an ultralow bias current monolithic operational
amplifier (OPA129 from TI).
Once set the maximum values of the voltage (Vmax,RE)
required for elicit specific electrochemical reaction, Vin was
imposed as reported in Fig. 3 and Vout was then measured
within the interval T, which specifically depends on both
Vmax.RE and the overall scan cycle duration (T ). The scan rate
is defined as the ratio between maximum voltage (Vmax,RE)
and the time required to reach this voltage (T /4).
After all the Surface Mounting Device (SMD) compo-
nents were soldered, the board was inserted in a metal-
lic box to avoid noises on the signal recording and to
improve the sensor sensitivity and precision. The output signal
(Vout) is acquired by Arduino UNO through the internal 10-
b analog-to-digital converter. Measurements are transmitted
wirelessly to a PC using the Bluetooth module. The trans-
mitted packet includes the time, Vin and Vout values, A
Virtual Instrument (VI) was developed to acquire and store
the data. Furthermore, through the VI the user can define
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Fig. 3. Schematic of the waveform of Vin produced by DAC (Left) and schematic of the circuit used as analog front end (Right).
the Vmax.RE and the T when the setup code of Arduino UNO
is executed. In this way, with the possibility of generalize
this approach, the PoC could be used for identifying several
biomarkers, by implementing different SPESs and function-
alization methods. Overall dimension of the proposed PoC
device is defined by the specific dimension of each of its
components: sensor 5.1 cm × 5.1 cm (with a specific active
area of each WE of 20 mm2, Fig. 2), PCB 7.6 cm × 3.3 cm,
and bluetooth module with Arduino 7.5 cm × 7 cm × 4.5 cm.
C. Calibration and Measurements
After optimizing the design and testing the compatibility
of the materials with wet lab techniques, the platform
was assessed by measuring output current, following three
different protocols: 1) using a saline solution, with different
concentrations of NaCl; 2) functionalizing the WE with
primary antibodies in presence of K3[Fe(CN)6] solution; and
3) performing ASV measurements to calibrate the platform
using Interleukin 8 (IL-8).
Both the input and the output signals were generated and
acquired respectively by using the portable wireless system
described in the previous paragraph. Experiments were always
performed in triplicate. All graphical and tabulated data were
usually reported as mean ± mean standard error. LOD for
IL-8 quantification was calculated using three-sigma limit
definition.
1) NaCl Solution Measurements: The first test of the circuit
was performed in order to assess its ability to detect small
changes in solution conductivity due to controlled variations
of NaCl concentration in deionized (DI) water. Specifically the
circuit was evaluated with concentrations lower than 1 mg/ml:
0, 0.44, 0.66, 0.88, and 1 mg/ml. In each experiment, drops of
200 μl of saline solution were released on the three electrodes,
ensuring that the drop stayed correctly in place by using a
mask applied on top of the sensor. For this analysis, Vmax,RE
and T were set to 300 mV and 25 s, respectively, and thus
the scan rate was 48 mV/s. The expected output was related
to a change in the intensity of current flowing between WE
and CE, which corresponds to a different concentration.
2) Antibodies Coating Quantification: The effectiveness
of primary antibodies coating on the WE was assessed by
evaluating changes in the current detected between WE and
CE at different scan rates with three antibodies concentrations:
Fig. 4. Sensor functionalization for ASV measurements.
0, 4, and 8 μg/ml. After an overnight incubation at 4 °C, the
measurements were performed in presence of a conductive
electrolytic solution of 5 mM K3[Fe(CN)6] in 1-M KCl. Once
the functionalization was performed, a drop of 200 μl was
placed in order to cover the electrodes and allow current flow.
Finally, the electronic measurements were performed at four
different scan rates (48, 120, 240, and 1.2 mV/s), with a
Vmax,RE of 300 mV.
3) Interleukin Quantification Using ASV: In order to
optimize the ASV protocol for biomarkers quantification
(Fig. 4), a preliminary curve was quantified using IL-8
protein, a member of the CXC chemokine subfamily.
Cytokines are important mediators of inflammation and are
usually associated with pathogenesis of many inflammatory
diseases. Therefore, IL-8 is currently being applied as
noninvasive diagnostic marker in various fields of medicine
either for the purpose of early diagnosis or as a prognosis
predictor [22]. Furthermore, recently, Ray et al. [23] has
identified 18 signaling proteins in blood plasma that can be
used to classify and predict clinical Alzheimer’s diagnosis,
among which IL-8 has been also identified. Therefore,
IL-8 can be considered as universal biomarkers—from cancer
and inflammation to neurodegeneration—thus generalizing
the use of the present PoC platform to various clinical fields.
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Fig. 5. Layout for IL-8 concentration test on multiwells sensor.
Moreover, in this validation phase, IL-8 strong interaction
with its capture antibody, allows to reduce the variability to
the functionalization phase. The protocol adopted for IL-8
quantification in this calibration phase of the circuit was
characterized by a specific functionalization of the sensor
using immunocomplexes formed by a capture and a detection
antibody, using a dedicated kit (DuoSet development system
for ELISA, Human CXCL8/IL-8). In particular, during the
functionalization step different concentration of IL-8 were
dropped on the multiwell sensor, as shown in Fig. 5.
In order to evaluate sensor LOD of IL-8, the platform
was calibrated using a range of concentrations usually easily
quantifiable using with ELISA assay, from 1.25 to 20 ng/ml.
In order to perform the detection step, the functionalization
was completed labeling the secondary antibodies with alkaline
phosphatase, an enzyme able to catalyze the reaction from
ionic silver of silver nitrate (AgNO3) to metallic silver, allow-
ing a selective deposition of silver, proportional to the amount
of protein recognized in the sample.
Thus, Ascorbic acid (AA-p) + 2Ag reacts in
Dehydroascorbic acid + 2H + 2Ag. After the deposition
step was completed, in order to perform the stripping step,
200 μl of buffer solution (1-M KCl) was dropped on the
three electrodes to allow current flow and Vmax,RE and T were
set, respectively, to 900 mV and 60 s, thus with a scan rate
of 60 mV/s. Finally, current flowing between WE and CE
due to Ag oxidation was measured, allowing a sensitive
quantification of proteins recognized on the sensor surface.
III. RESULTS
A. Calibration and Measurements
1) NaCl Solution Measurements: Results from the evalua-
tion of circuit response to changes in saline solution conduc-
tivity showed a linear increase of current peaks corresponding
to increasing NaCl concentrations. This finding was coher-
ent with literature since, as expected, the conductivity of a
specific solution has a positive linear relationship with its
concentration [24]. In particular, in the considered range of
concentrations, the circuit showed the ability to detect small
changes in solution conductivity corresponding to small values
of current flowing between WE and CE, thus reporting a
sensitivity of 0.15 mA/(mg/ml), with a current of 0.07 mA at
zero NaCl concentration, due to DI water conductivity (Fig. 6).
Fig. 6. Local maximum of the voltammograms peaks at different
concentrations of IL-8.
Fig. 7. Calibration of SPES with NaCl solution. (Error bars represent standard
deviations of measured data.)
2) Antibodies Coating Quantification: Results from
antibodies coating quantification showed a proportional
decrease of the current peak flowing between WE and CE,
for all the scan rates evaluated, indicating an increased
impedance of the system due to an increasing concentration
of antibodies coated on WE surfaces (Fig. 7).
This behavior comes from an increased portion of WE cov-
ered with primary antibodies, and, therefore, from a reduced
conductive surface of the electrode available to exchange
electrons with the electrolytic solution.
The sensitivity of the platform to quantify the concentration
of antibodies coated on the WE appears to be affected from
the scan rate of the input signal. In particular, a sensitivity
of 52 μA/μg was measured at 48 mV/s, of 90 μA/μg at
120 mV/s, of 128 μA/μg at 240 mV/s, and of 208 μA/μg
could be calculated for measurements performed at 1.2 V/s.
Comparing the variation observed between the current peaks
recorded using different scan rates, a more enhanced difference
could be observed at higher scan rates. Even though in all the
evaluated conditions an increase in the current peak recorded
can be observed when decreasing the antibodies concentration.
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Fig. 8. Differences between antibodies concentration detection at different
scan rates. (Error bars represent standard deviations of measured data.)
Fig. 9. Cyclic voltammograms, corresponding to different IL-8
concentrations.
For the bare sensor, where the entire surface is available for
electrons exchange with the electrolytic solution, an enhanced
difference between current recorded at different scan rates
could be observed, compared with the coated conditions. This
result suggested a good adhesion of the coated layer on the
WE, acting as an insulating layer.
3) Interleukin Quantification Using ASV: Results from ASV
measurements showed an increase in the maximum peak of
current proportional to the increase of IL-8 concentration. The
voltammograms plotted in Fig. 8 showed the anodic peak due
to the silver stripped in the buffer solution in a window of
positive potentials around 0.5 V, corresponding to the oxida-
tion potential of metallic silver deposited during the chemical
deposition step. Bare electrodes (dotted black line), just coated
with 8 μg/ml of primary antibody, showed a CV with a
current peak corresponding to 0.05 mA, value comparable with
the results obtained from antibodies quantification considering
a similar scan rate, as described in the previous paragraph.
Some differences could be observed between the baselines
corresponding to different electrodes and affecting the position
of the peaks, probably due to intrinsic variability in the
electrodes processing. Furthermore, also the local reaction
between the electrode and the buffer solution could influence
the baseline and may need to be analyzed further, in order to
improve the reliability of the final PoC. The local maximum
of the current peaks was calculated for each concentrations
and then plotted (Fig. 9).
Well defined current peaks could be observed for the tested
range of concentration from 1.25 to 20 ng/ml, with a sensitivity
of 38 μA/(ng/ml) and a LOD of 2 ng/ml. The choice of the
concentration tested in this phase form 1.25 to 20 ng/ml had
to take into account the limitation due to the technique and the
material (i.e., carbon ink) used to produce the WE. However,
these values are in accordance with the range adopted in
different works using ELISA assay.
IV. DISCUSSION AND CONCLUSION
The complexities and the heterogeneity associated with
AD require high precision and sensitivity in the reliable detec-
tion and quantification of specific biomarkers. This approach
could allow to obtain an early diagnosis of the disease in the
presymptomatic phase. Furthermore, the identification of spe-
cific biological markers could provide additional information
about the pathology development from both the biological and
patho-clinical point of view [19], [25]. In order to achieve
this goal efficiently, different characteristics of measuring
methodology—such as rapidity, low cost, and ease of access
and use—play a fundamental role. Furthermore, this need of
quantification has been rapidly growing also considering the
interest addressed toward personalized medicine and domicil-
iary diagnostics [1].
The proposed PoC platform presented high level of inte-
gration of different solutions, including SPES and wireless
transmission, in order to obtain a low cost and portable but
highly sensitive device.
From the characterization perspective, the results obtained,
confirmed the compatibility of the screen-printed materials for
the functionalization required for AD biomarkers detection
and wet lab practices. Furthermore, tests performed both with
NaCl solution and with K3[Fe(CN)6] solution validated the
ability of the designed circuit to effectively detect changes
in solution conductivity and system impedance, related to the
changes in the current flowing between WE and CE. Results
from the characterization with conductive solutions suggested
several properties. First of all, the ability of the circuit to
detect low changes in concentration, with good reproducibility
and reliable responses. Furthermore, the response recorded
for the electrode coated with 8 μg/ml of antibody anti-
IL-8 at the different frequencies could confirm the good
adhesion of the primary antibody on the WE, essential for
the effective realization of the complete immunocomplex.
Findings obtained from the calibration performed quantifying
IL-8 protein, showed a sensitivity of 38 μA/(ng/ml) and
a LOD of 2 ng/ml. These results appear to be promising
also compared with works where, using similar experiment
designs and ASV as detection method, a limit for a reliable
quantification of proteins was reported to be 10 ng/ml [7],
and 2.2 ng/ml [26], respectively. Decreasing the concentration
of IL-8, thus decreasing the amount of silver stripped,
ASV peaks appeared to be shifted toward decreasing poten-
This article has been accepted for inclusion in a future issue of this journal. Content is final as presented, with the exception of pagination.
TONELLO et al.: WIRELESS PoC PLATFORM 7
tials, due to the interaction between buffer solution and
electrode when redox reaction is limited.
In this research, we set up all the conditions in order to
develop a PoC device with a patented antibody recognizing
unfolded p53 and allowing the measurement of this biomarker
in AD patients. After the validation, the proposed methodology
and the platform designed will be optimized in order to be
easily accessible for a routine automatized diagnosis technique
in the clinical environment.
All this, with the aim to realize an innovative self-standing
portable point-of-care test system, representing a low cost,
easy to use, and highly precise platform able to support the
validation of a promising putative early biomarker for AD.
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